Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET
Company Participants
Danielle Dudgeon - Stern IR
Kevin Boyle Senior - CEO
Drew Deniger - VP, Research and Development
Abhi Srivastava - VP, Technical Operations
Mike Wong - VP, Finance
Conference Call Participants
Prakhar Agrawal - Cantor Fitzgerald
Yale Jen - Laidlaw
Thomas Flaten - Lake Street Capital Markets
Operator
Good day, and thank you for standing by. Welcome to the Alaunos Therapeutics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Danielle Dudgeon with Stern IR. Please go ahead.
Danielle Dudgeon
Good morning, and welcome to Alaunos Therapeutics fourth quarter and full year 2022 financial results conference call and audio webcast. Earlier this morning, Alaunos issued a press release announcing financial results for the three months and full year ended December 31, 2022. We encourage everyone to read today's press release, as well as the Alaunos annual report on Form 10-K for the quarter ended December 31, 2022, which was filed with the SEC this morning.
The company's press release and annual report will also be available one the Alaunos' website at alaunos.com. In addition, this conference call is being webcast through the Investor Relations section of the company's website, and will be archived there for future reference.
Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, March 7, 2023. Actual results could differ materially from those stated or implied by the forward-looking statements made today due to risks and uncertainties associated with the company's business.
Information on potential risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov. The company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this webcast, except as may be required by applicable securities law.
With me today are Kevin Boyle Senior, Chief Executive Officer; Drew Deniger, Vice President of Research and Development; Abhi Srivastava, Vice President of Technical Operations; and Mike Wong, Vice President of Finance.